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Abstract Vitamin D is lipophilic and accumulates substantially in adipose tissue. Even
without supplementation, the amount of vitamin D in the adipose of a typical
adult is equivalent to several months of the daily reference nutrient intake (RNI).
Paradoxically, despite the large amounts of vitamin D located in adipose tissue,
individuals with obesity are often vitamin D deficient according to consensus
measures of vitamin D status (serum 25-hydroxyvitamin D concentrations). Thus,
it appears that vitamin D can become ‘trapped’ in adipose tissue, potentially due
to insufficient lipolytic stimulation and/or due to tissue dysfunction/adaptation
resulting from adipose expansion. Emerging evidence suggests that exercise may
mobilise vitamin D from adipose (even in the absence of weight loss). If exercise
helps to mobilise vitamin D from adipose tissue, then this could have important
ramifications for practitioners and policymakers regarding the management of low
circulating levels of vitamin D, as well as chronically low levels of physical
activity, obesity and associated health conditions. This perspective led us to design
a study to examine the impact of exercise on vitamin D status, vitamin D turnover
and adipose tissue vitamin D content (the VitaDEx project). The VitaDEx project
will determine whether increasing physical activity (via exercise) represents a
potentially useful strategy to mobilise vitamin D from adipose tissue.
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Introduction
Vitamin D has effects far beyond its classical actions
on calcium homeostasis and bone metabolism, and
vitamin D insufficiency is thought to affect many phys-
iological systems and a wide array of human health
outcomes (Dobnig et al. 2008; Ginde et al. 2009;
Semba et al. 2010). Vitamin D status is conventionally
determined by measuring concentrations of the main
circulating form of vitamin D, 25-hydroxyvitamin D
[25(OH)D]. Approximately 30–40% of the UK popu-
lation have circulating 25(OH)D <25 nmol/l in winter
(SACN 2016), and the correction of low systemic con-
centrations of 25(OH)D is a recognised public health
priority (Palacios & Gonzalez 2014; Cashman et al.
2016).
Vitamin D: Overview
The two main forms of vitamin D are vitamin D2
(ergocalciferol) and vitamin D3 (cholecalciferol)
(Askew et al. 1930; Windaus et al. 1936). Previtamin
D3 is synthesised by the skin when solar ultraviolet
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(UV) radiation (wavelength 290–320 nm) penetrates
the skin and is absorbed by 7-dehydrocholesterol
(Maclaughlin et al. 1982), before spontaneously and
rapidly isomerising to vitamin D3. Vitamin D3 is meta-
bolised in the liver to 25(OH)D – the main circulating
form of vitamin D (Blunt et al. 1968; Blunt & Deluca
1969). Vitamin D2 and vitamin D3 can be obtained
from the diet and from supplements (Holick 2007).
Vitamin D2 is synthesised by UV irradiation of ergos-
terol and intake is primarily through consumption of
UV-irradiated mushrooms or supplements. In contrast,
vitamin D3 is more widely distributed in foods and is
more commonly used in supplements and fortified
foods than vitamin D2. One reason for using serum 25
(OH)D as a measure of vitamin D status is that it has
a half-life of ~2–3 weeks and, therefore, quantification
of this metabolite is not influenced by transient
changes in dietary vitamin D or acute sun exposure to
the same extent as other vitamin D metabolites (Jones
et al. 2015). The methods of assessing 25(OH)D are
reviewed by Le Goff et al. (2015). In this review, ref-
erence to ‘vitamin D’ denotes either vitamin D3 (chole-
calciferol) or 25(OH)D.
The main metabolically active form of vitamin D
in vivo is the seco-steroid 1,25-dihydroxyvitamin D
[1,25(OH)2D], also referred to as calcitriol. It is 1,25
(OH)2D that is generally considered responsible for
the physiological functions of vitamin D. The produc-
tion of 1,25(OH)2D takes place predominantly in the
kidney, and its action is mediated through binding to
a vitamin D receptor (VDR), which is usually located
in the nuclei of target cells, and which regulates target
gene expression when bound with 1,25(OH)2D (Haus-
sler et al. 2013). Study of VDR-ablated mice has
demonstrated numerous functions of vitamin D (Bouil-
lon et al. 2013).
Vitamin D binding protein (DBP) in serum binds to
different vitamin D metabolites with different affinity
(Daiger et al. 1975). Vitamin D is bound to DBP for
transport to relevant tissues and to regulate bioavail-
ability (Safadi et al. 1999). Normally ~85% of circu-
lating 1,25(OH)2D is bound to DBP, with ~0.4%
being free circulating (Bikle et al. 1984, 1985), and
~88% of circulating 25(OH)D is bound to DBP with
~0.04% free (Bikle et al. 1986). Vitamin D can also
be bound to albumin and chylomicrons of lipoproteins
at lower affinity (Haddad et al. 1993). Although the
majority of circulating vitamin D metabolites are
bound to DBP or albumin, there is currently consider-
able debate about whether bound or unbound forms
of vitamin D are biologically active (Bikle et al.
2017), with some tissues requiring uptake of
DBP-bound vitamin D and others appearing to access
free or unbound vitamin D (Chun et al. 2014).
Potentially meaningful quantities of vitamin D have
been observed in the skin, liver, skeletal muscle and
adipose tissue of humans (Mawer et al. 1972), with
evidence that extra-renal tissues (such as the placenta)
are capable of metabolising vitamin D (Weisman et al.
1979; Adams & Hewison 2012). The present review
will focus on the role of adipose tissue, exploring the
accumulation of vitamin D in this sizeable depot,
whilst also exploring the potential mechanisms under-
lying the mobilisation of vitamin D from adipose
within the context of well-established physiological
concepts.
Vitamin D accumulation in adipose
Vitamin D is lipophilic and early studies used radioac-
tive isotopes to demonstrate its accumulation in adi-
pose tissue (Rosenstreich et al. 1971; Mawer et al.
1972). Supplementing with 20 000 international units
(IU) of vitamin D3 per week for 3–5 years leads to a
substantial increase in vitamin D3 content in subcuta-
neous abdominal adipose tissue, approximately sixfold
greater than placebo (Didriksen et al. 2015). The
amount of 25(OH)D present in adipose explants
remained correlated with serum 25(OH)D concentra-
tions 1 year after supplementation had ceased (Marti-
naityte et al. 2017). Although it is worth noting that
values for serum 25(OH)D and adipose tissue vitamin
D3 measured in this study varied considerably between
participants, which may be explained by the fourfold
variation in body fat mass across the study popula-
tion. There is a positive linear correlation between
vitamin D3 concentrations in subcutaneous abdominal
adipose tissue and serum (Blum et al. 2008b). High
concentrations of vitamin D3 have been observed in
adipose tissue from various sites (perirenal, pericar-
dial, axillary and cervical) taken from humans who
were not known to be supplementing with vitamin D
(Lawson et al. 1986). Vitamin D storage was highly
variable between adipose depots (Lawson et al. 1986),
which may be driven by depot-specific differences in
adipose tissue blood flow or metabolism; differences
which have been identified when comparing subcuta-
neous abdominal adipose and gluteofemoral adipose
(Manolopoulos et al. 2010). Furthermore, the relative
amount of vitamin D (i.e. per gram of subcutaneous
abdominal adipose tissue) is highly variable between
individuals (Blum et al. 2008b; Pramyothin et al.
2011). It has recently been suggested that vitamin D
accumulates in greater concentrations in omental
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adipose than subcutaneous abdominal adipose (Car-
relli et al. 2017). However, given that the mass of sub-
cutaneous adipose tissue is fourfold to sixfold greater
than that of visceral adipose tissue (Ross et al. 2000;
Merlotti et al. 2017), the absolute capacity and accu-
mulation of vitamin D in subcutaneous adipose depots
is likely to be quantitatively more important. Nonethe-
less, further research is needed to understand both the
distribution and inter-/intra-individual variability of
vitamin D accumulation across different adipose
depots.
Whilst adipose can accumulate both vitamin D3 and
25(OH)D, the limited data available suggest that the
concentrations of vitamin D3 are much greater (Piccolo
et al. 2013; Didriksen et al. 2015). Published values for
the amount of vitamin D3 present in subcutaneous adi-
pose tissue vary substantially, ranging from ~4 to
~500 ng/g, suggesting large individual variability and
dependency on supplementation status (Didriksen et al.
2015). For an individual weighing 100 kg, with 40%
body fat, this may equate to 160–20 000 lg vitamin
D3, which is the equivalent to anywhere between 16
and 2000 days of the daily reference nutrient intake
(RNI) of total dietary vitamin D (10 lg) for the UK
population (Fig. 1). The median value for vitamin D3 in
adipose of non-supplementing humans with overweight
or obesity is 32 ng/g (Didriksen et al. 2015), which
equates to 128 days of the RNI. Thus, adipose tissue
has the potential to accumulate a substantial amount of
vitamin D, especially when adipose mass is expanded
(i.e. in overweight and obesity).
Obesity and vitamin D status
Individuals with obesity have lower circulating 25(OH)
D concentrations than individuals without obesity
(Compston et al. 1981; Bell et al. 1985; Liel et al.
1988; Vimaleswaran et al. 2013; Pereira-Santos et al.
2015; Walsh et al. 2016). The mechanisms explaining
this have been debated. One suggestion is that reduced
sunlight exposure is a behavioural tendency in individu-
als with obesity (Compston et al. 1981), but there is
limited empirical evidence to support this. Wortsman
et al. (2000) found that increases in serum 25(OH)D,
induced by UV exposure, were attenuated in individuals
with obesity, hypothesising that vitamin D is less
bioavailable because it is sequestered in the expanded
adipose tissue compartment. In support of this sugges-
tion, in individuals supplemented with 700 IU/day of
vitamin D for a year, the increase in serum 25(OH)D
was inversely related to body mass index (BMI) (Blum
et al. 2008a). Another study assessed serum 25(OH)D
responses across 90 days with ingestion of a single oral
bolus of 300 000 IU of vitamin D3 and showed that the
increase in serum 25(OH)D concentration was blunted
in individuals with overweight or obesity compared
with lean controls (Camozzi et al. 2016). Lower vita-
min D status has sometimes been attributed to volumet-
ric dilution, with regression analysis revealing body
mass as the strongest univariate predictor of vitamin D
status (Drincic et al. 2012). If volumetric dilution was
driving this observation, then lower vitamin D status
may also be associated with expansion of muscle (and
total) mass. However, when comparing winter levels
of serum 25(OH)D in a range of non-supplementing
athletes (rugby league players), significantly greater
mean serum 25(OH)D was observed compared with
non-supplementing, non-athlete controls despite mark-
edly greater body mass (reflective of large muscle mass)
(Close et al. 2013). Furthermore, in university athletes,
fat mass was a significant predictor of serum 25(OH)D
concentrations but fat-free mass was not (Heller et al.
2015). Collectively, these findings indicate that volu-
metric dilution per se does not explain the negative
associations between mass and vitamin D status. This
makes sense when considering the lipophilic nature of
vitamin D. Indeed, it seems likely that the detrimental
effect of obesity on vitamin D status is predominantly
due to specific expansion of adipose mass rather than
expansion of total mass or volume.
Early studies postulated that increased circulating
1,25(OH)2D with obesity reduces serum 25(OH)D by
reducing hepatic synthesis of 25(OH)D via negative
feedback (Bell et al. 1984, 1985). However, there is a
weak negative relationship between fat mass and cir-
culating 1,25(OH)2D (Parikh et al. 2004), calling into
question the existence of a negative feedback mecha-
nism by which production and accumulation of excess
1,25(OH)2D would reduce 25(OH)D synthesis. Alter-
natively, low circulating vitamin D in individuals with
Figure 1 The amount of vitamin D present in adipose tissue is likely to be
quantitatively important. When extrapolated, the amounts of vitamin D pre-
sent in the adipose tissue of an individual weighing 100 kg and with a body
fat percentage of 40% may equate to up to 2000 days of the daily recom-
mended nutrient intake (RNI) of vitamin D (10 lg) from dietary sources or
supplementation. [Colour ﬁgure can be viewed at wileyonlinelibrary.com]
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obesity may be attributable to increased metabolic
clearance and enhanced uptake of vitamin D by adi-
pose tissue (Liel et al. 1988). An upregulation of
enzymes responsible for metabolising 25(OH)D to
1,25(OH)2D is unlikely to contribute to decreased
serum 25(OH)D because of the significantly lower cir-
culating levels of 1,25(OH)2D relative to 25(OH)D
(~1:400) (Lips 2007). Wamberg et al. (2013) analysed
the expression of a number of vitamin D hydroxylases
in visceral and subcutaneous abdominal adipose tissue
of lean women and women with obesity. There was
no difference in CYP24A1 expression (a major enzyme
responsible for catabolising vitamin D) between lean
individuals and individuals with obesity. Similar
results have since been replicated in a cohort of indi-
viduals with obesity (Di Nisio et al. 2017). Together,
these studies suggest that CYP2J2-25-hydroxylation
and 1a-hydroxylation are impaired, rather than upreg-
ulated, in the adipose tissue of individuals with obe-
sity, so do not support the idea that the decreased
systemic 25(OH)D concentrations observed in obesity
are caused by increased metabolism of vitamin D in
adipose. Other recent investigations using stable iso-
topes indicate that there is no difference in the overall
25(OH)D half-life with obesity (Walsh et al. 2016).
Therefore, adipose does not seem to actively metabo-
lise more vitamin D in individuals with obesity and
there seems to be no effect of obesity on overall 25
(OH)D metabolism and turnover. Instead, the most
striking effect of obesity seems to be that adipose
becomes a sink or reservoir for vitamin D.
A role for vitamin D within adipose?
Adipose tissue comprises heterogeneous cells including
adipocytes, various immune cells and preadipocytes.
The cellular composition of adipose impacts on adi-
pose inflammation (Bourlier et al. 2008) and the secre-
tion of inflammatory mediators (Maury & Brichard
2010), which is particularly pertinent to individuals
with obesity as it contributes to systemic low-grade
inflammation (Trim et al. 2018).
Treatment of human adipocytes in vitro with 1,25
(OH)2D decreases secretion of interleukin 6 (Mutt et al.
2012), suggesting that 1,25(OH)2D inhibits phosphory-
lation of IкBa, which has an inhibitory effect on NF-кB
(Baeuerle & Baltimore 1988). NF-кB induces transcrip-
tion of pro-inflammatory pathways (Baldwin 1996), so
vitamin D is potentially anti-inflammatory for adipose
tissue if available to exert physiological actions. Vita-
min D might also be important for the formation of
new adipocytes, and this has been reviewed in detail
elsewhere (Dix et al. 2018). Peroxisome proliferator-
activated receptor gamma (PPARc) is thought to be the
‘master regulator’ of adipogenesis, with differentiation
maintained by concomitant expression of PPARc and
CCAAT enhancer-binding protein a (Rosen et al.
2002). Study of human preadipocytes suggests 1,25
(OH)2D promotes adipogenesis (Nimitphong et al.
2012). Narvaez et al. (2013) found similar effects in
human mesenchymal progenitor cells (hMPCs), where
1,25(OH)2D increased expression of adipogenic marker
genes including fatty acid synthase, fatty acid-binding
proteins and PPARc.
In vitro studies provide intriguing insights into
potential functions of vitamin D within adipose tissue
itself. Unfortunately, very little is known about the
amount/distribution of vitamin D metabolites and the
actions of 1,25(OH)2D in adipose tissue in vivo. Fur-
thermore, it is important to note that simple measure-
ment of vitamin D3 or 25(OH)D in adipose biopsy
samples does not reveal the extent to which active
1,25(OH)2D is available for biological activity.
The potentially positive effects of vitamin D on adi-
pose tissue physiology and function present a very
interesting avenue for further research. However, since
vitamin D is likely sequestered in lipid droplets of adi-
pocytes, it might only be expected to exert physiologi-
cal effects within adipose once mobilised into the
cytosol and/or interstitium. It is an intriguing paradox
that, in individuals with obesity, vitamin D seems to
be ‘trapped’ in the lipid droplets of adipocytes in very
close proximity to sites that may potentially benefit if
only it could be made bioavailable.
Physical activity/exercise and vitamin D
status
Physical activity is a powerful stimulus for lipid mobili-
sation from adipose tissue (Thompson et al. 2012). It
is therefore conceivable that vitamin D ‘trapped’ in
adipocytes is mobilised (along with stored lipid) by
physical activity. In support of this suggestion, associa-
tion studies consistently report greater serum 25(OH)D
concentrations in individuals who self-report higher
physical activity (Reinehr et al. 2007; Villareal et al.
2008; Chomistek et al. 2011; Mason et al. 2011; Gan-
gloff et al. 2015; Chin et al. 2017). One study using
objective measures of physical activity (hip-based
accelerometry) showed a trend for increased serum 25
(OH)D at higher physical activity levels (Klenk et al.
2015). Such associations have often been attributed to
confounding factors (e.g. active people spending more
time outside and receiving additional sunlight
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exposure), but recent studies indicate that exercise may
have a direct and causal effect on vitamin D status.
Spoo et al. (2015) found a progressive increase in
serum 25(OH)D in sled dogs performing prolonged
endurance exercise across 8 days. Dietary vitamin D
intake was controlled, there was no weight loss, and
confounding from sunlight exposure was mitigated by
the dogs’ thick fur coats (How et al. 1994). Further-
more, Sun et al. (2017) showed elevated serum 25
(OH)D concentrations in lean humans in response to
30 minutes of cycling exercise at 70% _VO2 peak
(Fig. 2a,b). The increase in circulating 25(OH)D was
observed immediately post-exercise and persisted for
24 hours. Interestingly, the strongest positive predictor
of increased 25(OH)D (incremental area under the
curve) across 24 hours was higher body fat percentage
(with no such relationship with fat-free mass). More
recently, the same group reported that 5 weeks of pro-
gressive endurance cycling exercise (30 minute bouts,
three bouts/week, 60–75% _VO2 peak) during winter
months prevented any reductions in serum 25(OH)D
concentrations in a small group of elderly men (Sun
et al. 2018) (Fig. 2c,d), independent from any changes
in adipose tissue mass. Collectively, these recent studies
indicate that exercise has a direct and causal effect on
25(OH)D concentrations – possibly through the mobil-
isation of adipose-derived vitamin D and/or 25(OH)D.
Lipolysis as a key mechanism of vitamin D
mobilisation with exercise?
During exercise, there is a rise in plasma glucagon,
adrenaline and atrial natriuretic peptide (ANP) (Galbo
et al. 1975; Bloom et al. 1976; Gyntelberg et al.
1977; Jezova et al. 1985; McMurray et al. 1987;
Moro et al. 2007) and a decrease in plasma insulin
(Hodgetts et al. 1991), concomitant with increased
adipose tissue blood flow (Thompson et al. 2012).
Glucagon, adrenaline and ANP are stimulatory lipoly-
tic hormones (Arner et al. 1990; Perea et al. 1995;
Moro et al. 2007) and suppression of insulin leads to
a potent increase in lipolysis (Jensen et al. 1989). This
leads to hydrolysis of triacylglycerol from the lipid
droplet of adipocytes by the action of adipose triglyc-
eride lipase (ATGL) (Jenkins et al. 2004; Villena et al.
2004; Zimmermann et al. 2004) and hormone-sensi-
tive lipase (HSL) (Vaughan et al. 1964). Exercise in
the fasted or the fed state leads to an approximate
twofold to threefold increase in adipose tissue lipolysis
(Wolfe et al. 1990; Klein et al. 1994; Enevoldsen et al.
2004) and, when stored triacylglycerol is hydrolysed,
vitamin D metabolites may also be released from the
lipid droplet (Fig. 3).
The lipolytic response of adipose tissue to exercise is
impaired in individuals with obesity. Ex vivo adipose
tissue explants from individuals with obesity display
reduced maximal lipolytic responses to adrenergic
stimulation compared with adipose from individuals
without obesity (Reynisdottir et al. 1994; Large et al.
1999; Hellstrom & Reynisdottir 2000), coinciding
with decreased gene expression of ATGL and HSL
(Large et al. 1999; Langin et al. 2005; Jocken et al.
2007; McQuaid et al. 2011). These findings are sup-
ported in vivo, as individuals with obesity display
lower rates of lipolysis during exercise than lean con-
trols (Stich et al. 2000; Mittendorfer et al. 2004).
Whilst this may protect individuals with obesity from
Figure 2 (a) The effect of 30 minutes of cycling exercise at 70%
_VO2 max on serum 25(OH)D concentrations in humans [redrawn using
data from Sun et al. (2017)]. Data shown are mean  standard error of the
mean (SEM) for men and women combined. (b) Mean change in serum 25
(OH)D concentrations following 30 minutes of cycling exercise at 70%
_VO2 max. Left-hand bar represents change from pre-exercise to immediately
post-exercise, right-hand bar represents change from pre-exercise to 24 hours
post-exercise [redrawn using data from Sun et al. (2017)]. (c) The effect of
5 weeks of progressive cycling endurance exercise (30 minute bouts,
3 bouts/week, from 60% to 75% _VO2 peak) during winter months on serum
25(OH)D [redrawn using data from Sun et al. (2018)]. Data shown are mean
SEM. (d) Mean change in serum 25(OH)D concentrations following
5 weeks of progressive cycling endurance exercise [redrawn using data from
Sun et al. (2018)]. [Colour ﬁgure can be viewed at wileyonlinelibrary.com]
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elevated circulating fatty acids (McQuaid et al. 2011),
it may also contribute to sequestration of vitamin D.
In support of this contention, adipose explants taken
from individuals with obesity release less vitamin D
when stimulated with lipolytic hormones than explants
from lean controls (Di Nisio et al. 2017). In this study,
mobilisation of vitamin D was proportional to both
the lipolytic response (glycerol release) and protein
expression of beta-adrenergic receptors (Di Nisio et al.
2017); further supporting the notion that vitamin D
mobilisation is inherently coupled to lipolysis.
Exercise may also target adipose tissue dysfunction
in obesity. It is well established that an increase in
physical activity chronically improves adipocyte
function (Thompson et al. 2012). Exercise training
increases sensitivity to various mediators such as insu-
lin and adrenaline in overweight/obese adipose tissue
(Thompson et al. 2012). It has also recently been
shown that trained individuals exhibit greater protein
content of lipolytic enzymes in subcutaneous abdomi-
nal adipose tissue (Bertholdt et al. 2018). Thus, in
addition to an acute effect on vitamin D release asso-
ciated with each exercise bout, regular exercise
improves adipocyte function and the capacity to
respond when stimulated, which may include the
capacity to mobilise vitamin D in response to multiple
stimuli (e.g. habitual physical activity, fasting and
stress).
Figure 3 Vitamin D and the adipocyte. We hypothesise that in the rested or fed state triacylglycerol and vitamin D metabolites are trapped in the lipid droplet
of adipocytes. When exposed to a lipolytic stimulus, triacylglycerol is liberated and this may coincide with mobilisation of vitamin D metabolites. ATGL, adipose
triglyceride lipase; HSL, hormone-sensitive lipase, TAG, triacylglycerol. [Colour ﬁgure can be viewed at wileyonlinelibrary.com]
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The effect of exercise on vitamin D
mobilisation: The VitaDEx project
The UK Biotechnology and Biological Sciences
Research Council (BBSRC) recently supported the Vita-
DEx project (‘Mobilising Vitamin D sequestered in adi-
pose tissue in humans with Exercise’; running from
October 2018 to October 2021). In VitaDEx, we will
examine the impact of increased exercise on whole-
body and adipose tissue vitamin D metabolism, along
with the pathways involved in vitamin D mobilisation
from adipose tissue. We will use a 10-week randomised
controlled trial in overweight men and women to deter-
mine the impact of exercise (versus control) on vitamin
D status and metabolism. Multiple vitamin D metabo-
lites including vitamin D3, 25(OH)D3, 25(OH)D2,
active vitamin D [1,25-dihydroxyvitamin D, 1,25
(OH)2D3] and other metabolites such as 24,25-dihy-
droxyvitamin D [24,25(OH)2D3] and 3-epi-25(OH)D
will be measured in serum using liquid chromatogra-
phy–mass spectrometry (LC-MS/MS) (Jenkinson et al.
2016). Turnover of 25(OH)D will be assessed using an
established stable isotope technique (with measurement
by LC-MS/MS) (Jones et al. 2016; Walsh et al. 2016).
We will determine whether the change in serum 25
(OH)D has a demonstrable effect on functional mea-
sures of bioavailability by culturing monocytes from a
single donor with media supplemented with participant
serum to assess the impact of different serum vitamin D
concentrations on monocyte function. In addition, mea-
sures in subcutaneous abdominal adipose biopsies and
fluxes across adipose tissue (arteriovenous differences)
will be combined to understand the impact of exercise
on the capacity to mobilise vitamin D from adipose tis-
sue. The acquired tissue samples will enable us to char-
acterise the biological pathways and mechanisms that
are involved in vitamin D mobilisation. In addition to
the intervention study, we will include a lean compara-
tor group to understand the independent effects of adi-
posity and contextualise the effects of exercise on
vitamin D mobilisation, status and metabolism.
Variability in UV-induced vitamin D synthesis is a
potential risk during intervention studies and, there-
fore, we will structure the experimental work to take
place during the winter months when there is little
vitamin D synthesis at the latitude where the trial will
be conducted (Webb et al. 1988). This restriction in
time for experimental work necessitates a pragmatic
approach to study design; thus, a 10-week exercise
intervention has been chosen to increase the available
window of time for participants to commence the
trial. A 10-week exercise intervention is also long
enough to impact on key measures of adipose tissue
function (Thompson et al. 2012). Furthermore, we
anticipate that serum 25(OH)D will decline during
10 weeks in winter in non-exercising control partici-
pants, such that protective effects of an exercise inter-
vention will be apparent over this timeframe. Notably,
all exercise undertaken by the exercise group will
occur indoors. Participants in the exercise group will
perform cardiovascular exercise training four times
per week, predominantly in the form of treadmill
walking and cycling. Exercise duration will be pro-
gressive, at an intensity that will be personalised to
participants, predominantly corresponding to maximal
rates of fat oxidation.
Another potential risk during exercise interventions is
variability in energy balance and weight loss due to
varying degrees of dietary compensation (Turner et al.
2010), so we will compensate for the increase in energy
expenditure with food prescribed to fully offset the
energy expended during exercise (thus maintaining
energy balance). Energy expenditure will be monitored
during exercise to enable us to replace the energy
expended with foods containing no vitamin D, and we
will verify the adequacy of this energy replacement by
monitoring changes in body composition via dual X-ray
absorptiometry (DEXA). Dietary intake will be
recorded with a 3-day weighed diet record in the week
prior to, and during the final week of, the intervention,
along with a retrospective food frequency questionnaire
at both time points to more specifically capture dietary
sources of vitamin D habitually consumed.
Conclusions
Vitamin D can accumulate in large amounts in adi-
pose tissue where it may become sequestered. Prelimi-
nary evidence indicates that exercise may be a
potential strategy to mobilise vitamin D from adipose
tissue. We will examine this concept in a new research
study (the VitaDEx project). This research will help us
to understand the impact of exercise on vitamin D sta-
tus and whether increasing physical activity represents
a potentially useful strategy to mobilise vitamin D
from adipose tissue. If exercise helps to mobilise vita-
min D from adipose, then this could have important
ramifications for practitioners and policymakers
regarding the management of (i) low vitamin D status,
(ii) obesity and associated conditions and (iii) low
levels of physical activity. Current public health strate-
gies typically approach vitamin D deficiency by
increasing intake and/or synthesis of vitamin D (e.g.
dietary supplementation or UV treatment). Notably,
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overweight/obesity reduces the impact of dietary sup-
plementation with vitamin D on 25(OH)D concentra-
tions (Arunabh et al. 2003; Snijder et al. 2005; Blum
et al. 2008a; Beydoun et al. 2010) and the systemic
25(OH)D response to UV irradiation is significantly
impaired (Wortsman et al. 2000). Thus, complement-
ing conventional intake/synthesis strategies with tech-
niques to mobilise endogenous vitamin D has the
capacity to mutually enhance the overall effectiveness
of interventions to improve vitamin D status.
Acknowledgements
This work is funded by a grant from BBSRC (BB/
R018928/1). KSJ and AK are supported by the
National Institute for Health Research (NIHR) Cam-
bridge Biomedical Research Centre (IS-BRC-1215-
20014). The NIHR Cambridge Biomedical Research
Centre is a partnership between Cambridge University
Hospitals NHS Foundation Trust and the University
of Cambridge, funded by the NIHR. The views
expressed are those of the authors and not necessarily
those of the NHS, the NIHR or the Department of
Health and Social Care.
Conflict of interest
The authors have no conflict of interest to disclose.
Author contribution
AH and DT conceptualised the work; AH and DT
wrote the first draft; JTG provided initial intellectual
insights; KSJ and MH provided further intellectual
insights; all authors edited the manuscript and all
authors agreed on the final version of the manuscript
prior to submission.
References
Adams JS & Hewison M (2012) Extrarenal expression of the 25-
hydroxyvitamin D-1-hydroxylase. Archives of Biochemistry and
Biophysics 523: 95–102.
Arner P, Kriegholm E, Engfeldt P et al. (1990) Adrenergic regulation
of lipolysis in situ at rest and during exercise. Journal of Clinical
Investigation 85: 893–8.
Arunabh S, Pollack S, Yeh J et al. (2003) Body fat content and 25-
hydroxyvitamin D levels in healthy women. The Journal of Clini-
cal Endocrinology and Metabolism 88: 157–61.
Askew FA, Bourdillon RB, Bruce HM et al. (1930) The distilla-
tion of vitamin D. Proceedings of the Royal Society 107:
76–90.
Baeuerle PA & Baltimore D (1988) IкB: a specific inhibitor of the
NF-кB transcription factor. Science 242: 540–6.
Baldwin AS (1996) The NF-кB and IкB proteins: new discoveries
and insights. Annual Review of Immunology 14: 649–83.
Bell NH, Shaw S & Turner RT (1984) Evidence that 1,25-dihydrox-
yvitamin-D-3 inhibits the hepatic production of 25-hydroxyvita-
min-D in man. Journal of Clinical Investigation 74: 1540–4.
Bell NH, Epstein S, Greene A et al. (1985) Evidence for alteration
of the vitamin D endocrine system in obese subjects. Journal of
Clinical Investigation 76: 370–3.
Bertholdt L, Gudiksen A, Stankiewicz T et al. (2018) Impact of
training state on fasting-induced regulation of adipose tissue
metabolism in humans. Journal of Applied Physiology 124:
729–40.
Beydoun MA, Boueiz A, Shroff MR et al. (2010) Associations
among 25-hydroxyvitamin D, diet quality, and metabolic distur-
bance differ by adiposity in adults in the United States. The Jour-
nal of Clinical Endocrinology and Metabolism 95: 3814–27.
Bikle DD, Gee E, Halloran B et al. (1984) Free 1,25-dihydroxyvita-
min-D levels in serum from normal subjects, pregnant subjects,
and subjects with liver-disease. Journal of Clinical Investigation
74: 1966–71.
Bikle DD, Siiteri PK, Ryzen E et al. (1985) Serum protein binding of
1,25-dihydroxyvitamin D: a reevaluation by direct measurement
of free metabolite levels. The Journal of Clinical Endocrinology &
Metabolism 61: 969–75.
Bikle DD, Gee E, Halloran B et al. (1986) Assessment of the free
fraction of 25-hydroxyvitamin-D in serum and its regulation by
albumin and the vitamin-D-binding protein. The Journal of Clini-
cal Endocrinology & Metabolism 63: 954–9.
Bikle D, Bouillon R, Thadhani R et al. (2017) Vitamin D metabo-
lites in captivity? Should we measure free or total 25(OH)D to
assess vitamin D status? The Journal of Steroid Biochemistry and
Molecular Biology 173: 105–16.
Bloom SR, Johnson RH, Park DM et al. (1976) Differences in the
metabolic and hormonal response to exercise between racing
cyclists and untrained individuals. The Journal of Physiology 258:
1–18.
Blum M, Dallal GE & Dawson-Hughes B (2008a) Body size and
serum 25 hydroxy vitamin D response to oral supplements in
healthy older adults. Journal of the American College of Nutrition
27: 274–9.
Blum M, Dolnikowski G, Seyoum E et al. (2008b) Vitamin D-3 in
fat tissue. Endocrine 33: 90–4.
Blunt JW & Deluca HF (1969) The synthesis of 25-hydroxycholecal-
ciferol. A biologically active metabolite of vitamin D3. Biochem-
istry 8: 671–5.
Blunt JW, Deluca HF & Schnoes HK (1968) 25-hydroxycholecalci-
ferol. A biologically active metabolite of vitamin D3. Biochemistry
7: 3317–22.
Bouillon R, Lieben L, Mathieu C et al. (2013) Vitamin D action:
lessons from VDR and Cyp27b1 null mice. Pediatric Endocrinol-
ogy Reviews 10 (Suppl 2): 354–66.
Bourlier V, Zakaroff-Girard A, Miranville A et al. (2008) Remodel-
ing phenotype of human subcutaneous adipose tissue macro-
phages. Circulation 117: 806–15.
Camozzi V, Frigo AC, Zaninotto M et al. (2016) 25-Hydroxychole-
calciferol response to single oral cholecalciferol loading in the
© 2019 The Authors. Nutrition Bulletin published by John Wiley & Sons Ltd on behalf of British Nutrition Foundation Nutrition Bulletin, 44, 25–35
32 A. Hengist et al.
normal weight, overweight, and obese. Osteoporosis International
27: 2593–602.
Carrelli A, Bucovsky M, Horst R et al. (2017) Vitamin D storage in
adipose tissue of obese and normal weight women. Journal of
Bone and Mineral Research 32: 237–42.
Cashman KD, Dowling KG, Skrabakova Z et al. (2016) Vitamin D
deficiency in Europe: pandemic? The American Journal of Clinical
Nutrition 103: 1033–44.
Chin K, Zhao D, Tibuakuu M et al. (2017) Physical activity, vita-
min D, and incident atherosclerotic cardiovascular disease in
whites and blacks: the ARIC study. The Journal of Clinical
Endocrinology and Metabolism 102: 1227–36.
Chomistek AK, Chiuve SE, Jensen MK et al. (2011) Vigorous physi-
cal activity, mediating biomarkers, and risk of myocardial infarc-
tion. Medicine & Science in Sports & Exercise 43: 1884–90.
Chun RF, Peercy BE, Orwoll ES et al. (2014) Vitamin D and DBP:
the free hormone hypothesis revisited. The Journal of Steroid Bio-
chemistry and Molecular Biology 144: 132–7.
Close GL, Russell J, Cobley JN et al. (2013) Assessment of vitamin
D concentration in non-supplemented professional athletes and
healthy adults during the winter months in the UK: implications
for skeletal muscle function. Journal of Sports Sciences 31:
344–53.
Compston JE, Vedi S, Ledger JE et al. (1981) Vitamin D status and
bone histomorphometry in gross obesity. The American Journal of
Clinical Nutrition 34: 2359–63.
Daiger SP, Schanfield MS & Cavallisforza LL (1975) Group-specific
component (Gc) proteins bind vitamin D and 25-hydroxyvitamin
D. Proceedings of the National Academy of Sciences of the United
States of America 72: 2076–80.
Di Nisio A, De Toni L, Sabovic I et al. (2017) Impaired release of
vitamin D in dysfunctional adipose tissue: new cues on vitamin D
supplementation in obesity. The Journal of Clinical Endocrinology
and Metabolism 102: 2564–74.
Didriksen A, Burild A, Jakobsen J et al. (2015) Vitamin D-3
increases in abdominal subcutaneous fat tissue after supplementa-
tion with vitamin D-3. European Journal of Endocrinology 172:
235–41.
Dix CF, Barcley JL & Wright ORL (2018) The role of vitamin D in
adipogenesis. Nutrition Reviews 76: 47–59.
Dobnig H, Pilz S, Scharnagl H et al. (2008) Independent association
of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d
levels with all-cause and cardiovascular mortality. Archives of
Internal Medicine 168: 1340–9.
Drincic AT, Armas LAG, Van Diest EE et al. (2012) Volumetric
Dilution, rather than sequestration best explains the low vitamin
D status of obesity. Obesity 20: 1444–8.
Enevoldsen LH, Simonsen L, Macdonald IA et al. (2004) The
combined effects of exercise and food intake on adipose tissue
and splanchnic metabolism. The Journal of Physiology 561:
871–82.
Galbo H, Holst JJ & Christensen NJ (1975) Glucagon and plasma
catecholamine responses to graded exercise and prolonged exercise
in man. Journal of Applied Physiology 38: 70–6.
Gangloff A, Bergeron J, Pelletier-Beaumont E et al. (2015) Effect of
adipose tissue volume loss on circulating 25-hydroxyvitamin D
levels: results from a 1-year lifestyle intervention in viscerally
obese men. International Journal of Obesity 39: 1638–43.
Ginde AA, Scragg R, Schwartz RS et al. (2009) Prospective study of
serum 25-hydroxyvitamin D level, cardiovascular disease mortal-
ity, and all-cause mortality in older U.S. adults. Journal of the
American Geriatrics Society 57: 1595–603.
Gyntelberg F, Rennie MJ, Hickson RC et al. (1977) Effect of train-
ing on the response of plasma glucagon to exercise. Journal of
Applied Physiology 43: 302–5.
Haddad JG, Matsuoka LY, Hollis BW et al. (1993) Human plasma
transport of vitamin D after its endogenous synthesis. Journal of
Clinical Investigation 91: 2552–5.
Haussler MR, Whitfield GK, Kaneko I et al. (2013) Molecular
mechanisms of vitamin D action. Calcified Tissue International
92: 77–98.
Heller JE, Thomas JJ, Hollis BW et al. (2015) Relation between
vitamin D status and body composition in collegiate athletes.
International Journal of Sport Nutrition and Exercise Metabolism
25: 128–35.
Hellstrom L & Reynisdottir S (2000) Influence of heredity for obe-
sity on adipocyte lipolysis in lean and obese subjects. International
Journal of Obesity and Related Metabolic Disorders 24: 340–4.
Hodgetts V, Coppack SW, Frayn KN et al. (1991) Factors control-
ling fat mobilization from human subcutaneous adipose tissue
during exercise. Journal of Applied Physiology 71: 445–51.
Holick MF (2007) Vitamin D deficiency. The New England Journal
of Medicine 357: 266–81.
How KL, Hazewinkel HA & Mol JA (1994) Dietary vitamin D
dependence of cat and dog due to inadequate cutaneous synthesis
of vitamin D. General and Comparative Endocrinology 96: 12–8.
Jenkins CM, Mancuso DJ, Yan W et al. (2004) Identification, cloning,
expression, and purification of three novel human calcium-indepen-
dent phospholipase A(2) family members possessing triacylglycerol
lipase and acylglycerol transacylase activities. Journal of Biological
Chemistry 279: 48968–75.
Jenkinson C, Taylor AE, Hassan-Smith ZK et al. (2016) High
throughput LC-MS/MS method for the simultaneous analysis of
multiple vitamin D analytes in serum. Journal of Chromatography
B, Analytical Technologies in the Biomedical and Life Sciences
1014: 56–63.
Jensen MD, Caruso M, Heiling V et al. (1989) Insulin regulation of
lipolysis in nondiabetic and IDDM subjects. Diabetes 38:
1595–601.
Jezova D, Vigas M, Tatar P et al. (1985) Plasma testosterone and
catecholamine responses to physical exercise of different intensities
in man. European Journal of Applied Physiology and Occupa-
tional Physiology 54: 62–6.
Jocken JW, Langin D, Smit E et al. (2007) Adipose triglyceride
lipase and hormone-sensitive lipase protein expression is decreased
in the obese insulin-resistant state. The Journal of Clinical
Endocrinology & Metabolism 92: 2292–9.
Jones KS, Assar S, Vanderschueren D et al. (2015) Predictors of 25
(OH)D half-life and plasma 25(OH)D concentration in The Gam-
bia and the UK. Osteoporosis International 26: 1137–46.
Jones KS, Assar S, Prentice A et al. (2016) Vitamin D expenditure is
not altered in pregnancy and lactation despite changes in vitamin
D metabolite concentrations. Scientific Reports 6: 26795.
Klein S, Coyle EF & Wolfe RR (1994) Fat metabolism during low-
intensity exercise in endurance-trained and untrained men. Ameri-
can Journal of Physiology 267: E934–40.
© 2019 The Authors. Nutrition Bulletin published by John Wiley & Sons Ltd on behalf of British Nutrition Foundation Nutrition Bulletin, 44, 25–35
Vitamin D, adipose, and exercise 33
Klenk J, Rapp K, Denkinger M et al. (2015) Objectively measured
physical activity and vitamin D status in older people from
Germany. Journal of Epidemiology and Community Health 69:
388–92.
Langin D, Dicker A, Tavernier G et al. (2005) Adipocyte lipases
and defect of lipolysis in human obesity. Diabetes 54: 3190–7.
Large V, Reynisdottir S, Langin D et al. (1999) Decreased expres-
sion and function of adipocyte hormone-sensitive lipase in subcu-
taneous fat cells of obese subjects. Journal of Lipid Research 40:
2059–66.
Lawson DEM, Douglas J, Lean M et al. (1986) Estimation of vita-
min D3 and 25-hydroxyvitamin D3 in muscle and adipose tissue
of rats and man. Clinica Chimica Acta 157: 175–81.
Le Goff C, Cavalier E, Souberbielle JC et al. (2015) Measurement
of circulating 25-hydroxyvitamin D: a historical review. Practical
Laboratory Medicine 2: 1–14.
Liel Y, Ulmer E, Shary J et al. (1988) Low circulating vitamin D in
obesity. Calcified Tissue International 43: 199–201.
Lips P (2007) Relative value of 25(OH)D and 1,25(OH)2D mea-
surements. Journal of Bone and Mineral Research 22: 1668–71.
Maclaughlin JA, Anderson RR & Holick MF (1982) Spectral char-
acter of sunlight modulates photosynthesis of previtamin D3 and
its photoisomers in human skin. Science 216: 1001–3.
Manolopoulos KN, Karpe F & Frayn KN (2010) Gluteofemoral
body fat as a determinant of metabolic health. International Jour-
nal of Obesity 34: 949–59.
Martinaityte I, Kamycheva E, Didriksen A et al. (2017) Vitamin D
stored in fat tissue during a 5-year intervention affects serum 25-
hydroxyvitamin D levels the following year. The Journal of Clini-
cal Endocrinology & Metabolism 102: 3731–8.
Mason C, Xiao L, Imayama I et al. (2011) Effects of weight loss on
serum vitamin D in postmenopausal women. The American Jour-
nal of Clinical Nutrition 94: 95–103.
Maury E & Brichard SM (2010) Adipokine dysregulation, adipose
tissue inflammation and metabolic syndrome. Molecular and Cel-
lular Endocrinology 314: 1–16.
Mawer EB, Stanbury SW, Backhous J et al. (1972) The distribution
and storage of vitamin D and its metabolites in human tissues.
Clinical Science 43: 413–31.
McMurray RG, Forsythe WA, Mar MH et al. (1987) Exercise inten-
sity-related responses of b-endorphin and catecholamines. Medi-
cine and Science in Sports and Exercise 19: 570–4.
McQuaid SE, Hodson L, Neville MJ et al. (2011) Downregulation
of adipose tissue fatty acid trafficking in obesity: a driver for ecto-
pic fat deposition? Diabetes 60: 47–55.
Merlotti C, Ceriani V, Morabito A et al. (2017) Subcutaneous fat
loss is greater than visceral fat loss with diet and exercise, weight-
loss promoting drugs and bariatric surgery: a critical review and
meta-analysis. International Journal of Obesity 41: 672–82.
Mittendorfer B, Fields DA & Klein S (2004) Excess body fat in men
decreases plasma fatty acid availability and oxidation during
endurance exercise. American Journal of Physiology-Endocrinol-
ogy and Metabolism 286: E354–62.
Moro C, Pillard F, de Glisezinski I et al. (2007) Sex differences in
lipolysis-regulating mechanisms in overweight subjects: effect of
exercise intensity. Obesity 15: 2245–55.
Mutt SJ, Karhu T, Lehtonen S et al. (2012) Inhibition of cytokine
secretion from adipocytes by 1,25-dihydroxyvitamin D(3) via the
NF-kappaB pathway. The FASEB Journal 26: 4400–7.
Narvaez CJ, Simmons KM, Brunton J et al. (2013) Induction of
STEAP4 correlates with 1,25-dihydroxyvitamin D3 stimulation of
adipogenesis in mesenchymal progenitor cells derived from human
adipose tissue. Journal of Cellular Physiology 228: 2024–36.
Nimitphong H, Holick MF, Fried SK et al. (2012) 25-hydroxyvita-
min D-3 and 1,25-dihydroxyvitamin D-3 promote the differentia-
tion of human subcutaneous preadipocytes. PLoS ONE 7:
e52171.
Palacios C & Gonzalez L (2014) Is vitamin D deficiency a major
global public health problem? The Journal of Steroid Biochemistry
and Molecular Biology 144: 138–45.
Parikh SJ, Edelman M, Uwaifo GI et al. (2004) The relationship
between obesity and serum 1,25-dihydroxy vitamin D concentra-
tions in healthy adults. The Journal of Clinical Endocrinology &
Metabolism 89: 1196–9.
Perea A, Clemente F, Martinell J et al. (1995) Physiological effect of
glucagon in human isolated adipocytes. Hormone and Metabolic
Research 27: 372–5.
Pereira-Santos M, Costa PR, Assis AM et al. (2015) Obesity and
vitamin D deficiency: a systematic review and meta-analysis.
Obesity Reviews 16: 341–9.
Piccolo BD, Dolnikowski G, Seyoum E et al. (2013) Association
between subcutaneous white adipose tissue and serum 25-hydroxy-
vitamin D in overweight and obese adults. Nutrients 5: 3352–66.
Pramyothin P, Biancuzzo RM, Lu Z et al. (2011) Vitamin D in
adipose tissue and serum 25-hydroxyvitamin D after Roux-en-Y
Gastric Bypass. Obesity 19: 2228–34.
Reinehr T, de Sousa G, Alexy U et al. (2007) Vitamin D status and
parathyroid hormone in obese children before and after weight
loss. European Journal of Endocrinology 157: 225–32.
Reynisdottir S, Ellerfeldt K, Wahrenberg H et al. (1994) Multiple
lipolysis defects in the insulin resistance (metabolic) syndrome.
Journal of Clinical Investigation 93: 2590–9.
Rosen ED, Hsu CH, Wang XZ et al. (2002) C/EBP alpha induces
adipogenesis through PPAR gamma: a unified pathway. Genes &
Development 16: 22–6.
Rosenstreich SJ, Rich C & Volwiler W (1971) Deposition in and
release of vitamin D3 from body fat: evidence for a storage site in
the rat. Journal of Clinical Investigation 50: 679–87.
Ross R, Dagnone D, Jones PJ et al. (2000) Reduction in obesity and
related comorbid conditions after diet-induced weight loss or exer-
cise-induced weight loss in men. a randomized, controlled trial.
Annals of Internal Medicine 133: 92–103.
SACN (Scientific Advisory Committee on Nutrition) (2016) Vitamin
D and Health. SACN: London, UK.
Safadi FF, Thornton P, Magiera H et al. (1999) Osteopathy and
resistance to vitamin D toxicity in mice null for vitamin D binding
protein. Journal of Clinical Investigation 103: 239–51.
Semba RD, Houston DK, Bandinelli S et al. (2010) Relationship of
25-hydroxyvitamin D with all-cause and cardiovascular disease
mortality in older community-dwelling adults. European Journal
of Clinical Nutrition 64: 203–9.
Snijder MB, van Dam RM, Visser M et al. (2005) Adiposity in rela-
tion to vitamin D status and parathyroid hormone levels: a popu-
lation-based study in older men and women. The Journal of
Clinical Endocrinology & Metabolism 90: 4119–23.
Spoo JW, Downey RL, Griffitts C et al. (2015) Plasma vitamin D
metabolites and C-reactive protein in stage-stop racing endurance
sled dogs. Journal of Veterinary Internal Medicine 29: 519–25.
© 2019 The Authors. Nutrition Bulletin published by John Wiley & Sons Ltd on behalf of British Nutrition Foundation Nutrition Bulletin, 44, 25–35
34 A. Hengist et al.
Stich V, De Glisezinski I, Crampes F et al. (2000) Activation of
alpha(2)-adrenergic receptors impairs exercise-induced lipolysis in
SCAT of obese subjects. American Journal of Physiology-Regula-
tory, Integrative and Comparative Physiology 279: R499–504.
Sun X, Cao ZB, Taniguchi H et al. (2017) Effect of an acute bout
of endurance exercise on serum 25(OH)D concentrations in young
adults. The Journal of Clinical Endocrinology & Metabolism 102:
3937–44.
Sun X, Cao ZB, Tanisawa K et al. (2018) Effects of chronic endur-
ance exercise training on serum 25(OH)D concentrations in
elderly Japanese men. Endocrine 59: 330–7.
Thompson D, Karpe F, Lafontan M et al. (2012) Physical activity
and exercise in the regulation of human adipose tissue physiology.
Physiological Reviews 92: 157–91.
Trim W, Turner JE & Thompson D (2018) Parallels in immunome-
tabolic adipose tissue dysfunction with ageing and obesity. Fron-
tiers in Immunology 9: 1–22.
Turner JE, Markovitch D, Betts JA et al. (2010) Nonprescribed
physical activity energy expenditure is maintained with structured
exercise and implicates a compensatory increase in energy intake.
The American Journal of Clinical Nutrition 92: 1009–16.
Vaughan M, Berger JE & Steinberg D (1964) Hormone-sensitive
lipase and monoglyceride lipase activities in adipose tissue. Jour-
nal of Biological Chemistry 239: 401–9.
Villareal DT, Shah K, Banks MR et al. (2008) Effect of weight loss
and exercise therapy on bone metabolism and mass in obese older
adults: a one-year randomized controlled trial. The Journal of
Clinical Endocrinology & Metabolism 93: 2181–7.
Villena JA, Roy S, Sarkadi-Nagy E et al. (2004) Desnutrin, an adi-
pocyte gene encoding a novel patatin domain-containing protein,
is induced by fasting and glucocorticoids. Journal of Biological
Chemistry 279: 47066–75.
Vimaleswaran KS, Berry DJ, Lu C et al. (2013) Causal relationship
between obesity and vitamin D status: bi-directional mendelian
randomization analysis of multiple cohorts. PLOS Medicine 10:
e1001383.
Walsh JS, Evans AL, Bowles S et al. (2016) Free 25-hydroxyvitamin
D is low in obesity, but there are no adverse associations with bone
health. The American Journal of Clinical Nutrition 103: 1465–71.
Wamberg L, Christiansen T, Paulsen SK et al. (2013) Expression of
vitamin D-metabolizing enzymes in human adipose tissue-the
effect of obesity and diet-induced weight loss. International Jour-
nal of Obesity 37: 651–7.
Webb AR, Kline L & Holick MF (1988) Influence of season and lat-
itude on the cutaneous synthesis of vitamin D3: exposure to win-
ter sunlight in Boston and Edmonton will not promote vitamin
D3 synthesis in human skin. The Journal of Clinical Endocrinol-
ogy & Metabolism 67: 373–8.
Weisman Y, Harell A, Edelstein S et al. (1979) 1 alpha, 25-Dihy-
droxyvitamin D3 and 24,25-dihydroxyvitamin D3 in vitro synthe-
sis by human decidua and placenta. Nature 281: 317–9.
Windaus A, Schenck FR & Fv Werder (1936) The anti-rachitically
active irradiation product from 7-dehydro-cholesterol. Hoppe-Sey-
ler’s Zeitschrift fur physiologische Chemie 241: 100–3.
Wolfe RR, Klein S, Carraro F et al. (1990) Role of triglyceride-fatty
acid cycle in controlling fat metabolism in humans during and
after exercise. American Journal of Physiology 258: E382–9.
Wortsman J, Matsuoka LY, Chen TC et al. (2000) Decreased
bioavailability of vitamin D in obesity. The American Journal of
Clinical Nutrition 72: 690–3.
Zimmermann R, Strauss JG, Haemmerle G et al. (2004) Fat mobi-
lization in adipose tissue is promoted by adipose triglyceride
lipase. Science 306: 1383–6.
© 2019 The Authors. Nutrition Bulletin published by John Wiley & Sons Ltd on behalf of British Nutrition Foundation Nutrition Bulletin, 44, 25–35
Vitamin D, adipose, and exercise 35
